+

WO2003000929A3 - Polynucleotides, polypeptides et cancer - Google Patents

Polynucleotides, polypeptides et cancer Download PDF

Info

Publication number
WO2003000929A3
WO2003000929A3 PCT/JP2002/006363 JP0206363W WO03000929A3 WO 2003000929 A3 WO2003000929 A3 WO 2003000929A3 JP 0206363 W JP0206363 W JP 0206363W WO 03000929 A3 WO03000929 A3 WO 03000929A3
Authority
WO
WIPO (PCT)
Prior art keywords
san
polypeptides
cancer
polynucleotides
methods
Prior art date
Application number
PCT/JP2002/006363
Other languages
English (en)
Other versions
WO2003000929A2 (fr
Inventor
Yohei Ozeki
Takehiro Hirai
Ichiro Kawashima
Original Assignee
Sankyo Co
Yohei Ozeki
Takehiro Hirai
Ichiro Kawashima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co, Yohei Ozeki, Takehiro Hirai, Ichiro Kawashima filed Critical Sankyo Co
Priority to AU2002314552A priority Critical patent/AU2002314552A1/en
Publication of WO2003000929A2 publication Critical patent/WO2003000929A2/fr
Publication of WO2003000929A3 publication Critical patent/WO2003000929A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention porte sur des polypeptides et des polynucléotides SAN O787 1, SAN O399 3, SAN O437 1, SAN O437 4, et SAN O817 1 et sur des procédés de fabrication de tels polypeptides grâce à des techniques recombinantes. SAN 0787 1 présente un intérêt particulier puisque des niveaux plus élevés d'expression sont associés avec le cancer du foie. L'invention concerne aussi des procédés de diagnostic du cancer, notamment du cancer du foie, ainsi que leurs aspects correspondants. Elle se rapporte également à des procédés d'utilisation de polypeptides et des polynucléotides SAN O787 1, SAN O399 3, SAN O437 1, SAN O437 4, et SAN O817 1 dans la conception de protocoles et de réactifs pour des traitements thérapeutiques.
PCT/JP2002/006363 2001-06-26 2002-06-25 Polynucleotides, polypeptides et cancer WO2003000929A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002314552A AU2002314552A1 (en) 2001-06-26 2002-06-25 Polynucleotides polypeptides and cancer

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30089701P 2001-06-26 2001-06-26
US60/300,897 2001-06-26
US30175101P 2001-06-27 2001-06-27
US60/301,751 2001-06-27

Publications (2)

Publication Number Publication Date
WO2003000929A2 WO2003000929A2 (fr) 2003-01-03
WO2003000929A3 true WO2003000929A3 (fr) 2003-11-27

Family

ID=26972031

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/006363 WO2003000929A2 (fr) 2001-06-26 2002-06-25 Polynucleotides, polypeptides et cancer

Country Status (2)

Country Link
AU (1) AU2002314552A1 (fr)
WO (1) WO2003000929A2 (fr)

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013221A1 (fr) * 1991-12-23 1993-07-08 Chiron Corporation Sondes pour chlamydiae utilisees dans des methodes d'hybridation en sandwich en phase de solution
CA2113957A1 (fr) * 1993-01-29 1994-07-30 University Of Guelph Sequences nucleotidiques pour la determination du sexe des bovins
WO1999005274A1 (fr) * 1997-07-23 1999-02-04 Smithkline Beecham Corporation Procede servant a identifier de nouveaux recepteurs de proteines g et leurs fonctions
WO1999006830A1 (fr) * 1997-07-30 1999-02-11 The Regents Of The University Of California Procede servant a moduler des recepteurs couples a une proteine g
WO1999043811A1 (fr) * 1998-02-25 1999-09-02 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Adn complementaires codant un gene bog (b5t-over-expressed gene) et son produit proteinique
WO1999057269A1 (fr) * 1998-04-30 1999-11-11 Sumitomo Electric Industries, Ltd. Gene hrpi humain
WO2000023625A2 (fr) * 1998-10-22 2000-04-27 Ludwig Institute For Cancer Research Molecules isolees d'acide nucleique codant des proteines scp et leur utilisation
EP1016717A1 (fr) * 1997-06-26 2000-07-05 Sumitomo Electric Industries, Limited Nouvelle proteine ayant une excellente expression dans le cancer du sang, gene codant cette proteine, anticorps dirigee contre cette derniere et procede de detection de l'expression de cette proteine
WO2001027158A2 (fr) * 1999-10-08 2001-04-19 Digiscents Sequences de recepteurs olfactifs
WO2002010202A2 (fr) * 2000-07-26 2002-02-07 Curagen Corporation Nouvelles proteines et nouveaux acides nucleiques codant celles-ci
WO2002012343A2 (fr) * 2000-08-07 2002-02-14 Curagen Corporation Nouvelles proteines et acides nucleiques les codant
WO2002026985A2 (fr) * 2000-09-28 2002-04-04 Curagen Corporation Nouvelles proteines et acides nucleiques codant ces proteines
WO2002046229A2 (fr) * 2000-12-05 2002-06-13 Curagen Corporation Nouvelles proteines et acides nucleiques codant celles-ci
WO2002050276A2 (fr) * 2000-12-18 2002-06-27 Curagen Corporation Nouvelle proteine et acides nucleiques codant pour celle-ci
WO2002055558A2 (fr) * 2000-12-18 2002-07-18 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour ces proteines

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013221A1 (fr) * 1991-12-23 1993-07-08 Chiron Corporation Sondes pour chlamydiae utilisees dans des methodes d'hybridation en sandwich en phase de solution
CA2113957A1 (fr) * 1993-01-29 1994-07-30 University Of Guelph Sequences nucleotidiques pour la determination du sexe des bovins
EP1016717A1 (fr) * 1997-06-26 2000-07-05 Sumitomo Electric Industries, Limited Nouvelle proteine ayant une excellente expression dans le cancer du sang, gene codant cette proteine, anticorps dirigee contre cette derniere et procede de detection de l'expression de cette proteine
WO1999005274A1 (fr) * 1997-07-23 1999-02-04 Smithkline Beecham Corporation Procede servant a identifier de nouveaux recepteurs de proteines g et leurs fonctions
WO1999006830A1 (fr) * 1997-07-30 1999-02-11 The Regents Of The University Of California Procede servant a moduler des recepteurs couples a une proteine g
WO1999043811A1 (fr) * 1998-02-25 1999-09-02 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Adn complementaires codant un gene bog (b5t-over-expressed gene) et son produit proteinique
WO1999057269A1 (fr) * 1998-04-30 1999-11-11 Sumitomo Electric Industries, Ltd. Gene hrpi humain
WO2000023625A2 (fr) * 1998-10-22 2000-04-27 Ludwig Institute For Cancer Research Molecules isolees d'acide nucleique codant des proteines scp et leur utilisation
WO2001027158A2 (fr) * 1999-10-08 2001-04-19 Digiscents Sequences de recepteurs olfactifs
WO2002010202A2 (fr) * 2000-07-26 2002-02-07 Curagen Corporation Nouvelles proteines et nouveaux acides nucleiques codant celles-ci
WO2002012343A2 (fr) * 2000-08-07 2002-02-14 Curagen Corporation Nouvelles proteines et acides nucleiques les codant
WO2002026985A2 (fr) * 2000-09-28 2002-04-04 Curagen Corporation Nouvelles proteines et acides nucleiques codant ces proteines
WO2002046229A2 (fr) * 2000-12-05 2002-06-13 Curagen Corporation Nouvelles proteines et acides nucleiques codant celles-ci
WO2002050276A2 (fr) * 2000-12-18 2002-06-27 Curagen Corporation Nouvelle proteine et acides nucleiques codant pour celle-ci
WO2002055558A2 (fr) * 2000-12-18 2002-07-18 Curagen Corporation Nouvelles proteines et acides nucleiques codant pour ces proteines
WO2002059313A2 (fr) * 2000-12-18 2002-08-01 Curagen Corporation Nouvelles proteines, et acides nucleiques codant pour elles

Also Published As

Publication number Publication date
WO2003000929A2 (fr) 2003-01-03
AU2002314552A1 (en) 2003-01-08

Similar Documents

Publication Publication Date Title
EP1001023A3 (fr) Frizzled-4, un possible récepteur pour Wnt
EP0939124A3 (fr) Séquences de la MBGP1
AU2001251084A1 (en) Polynucleotides and polypeptides as well as methods for diagnosing and treating lung cancer
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2001066690A3 (fr) Nouveaux composes
WO1999035266A3 (fr) Urotensine humaine ii
EP0911399A3 (fr) HTHBZ47, un clone apparenté à une kringle
WO2001004141A3 (fr) Seripancrine
EP0943684A3 (fr) Polypeptides et polynucléotides ressemblant à frizzled
EP0879888A3 (fr) Polypeptides patched-2 et polynucléotides et leurs procédés de fabrication
EP0885959A3 (fr) Protéine Wnt-5b humaine
WO2003000929A3 (fr) Polynucleotides, polypeptides et cancer
WO2001083744A3 (fr) Nouvelle proteine echangeuse sodium-calcium
WO2002004600A3 (fr) Nouveaux composes
EP0890646A3 (fr) HE2NW40 Sérine protéase
WO2001068816A8 (fr) Variant-3 du gene humain de l'histamine h3
WO1999011783A3 (fr) Polypeptides de boite t
WO2001085921A3 (fr) Nouvelle serine-threonine kinase-4
EP0911391A3 (fr) Clone HWHHJ20
WO1999038885A3 (fr) Nouveaux composes
EP0937777A3 (fr) Récepteurs de GABA et leurs utilisations
EP0897009A3 (fr) HKABY60 polypeptides
EP0881291A3 (fr) Polypeptides CBS2, membres de la famille du facteur d'échange de la guanine
WO2001083768A3 (fr) Nouvelle serine-threonine kinase
WO2001085954A3 (fr) Nouvelle serine-threonine kinase-3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载